About 1,460 results

ALLMedicine™ Anticoagulation Center

Research & Reviews  531 results

High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel.
Pharmacology M'Pembele R, Ahlbrecht S et. al.

Dec 5th, 2022 - Antithrombotic regimen in patients on oral anticoagulation (OAC) post-percutaneous coronary intervention (PCI) is challenging. At least, one antiplatelet agent in combination with OAC is recommended after PCI for 6-12 months. Clopidogrel is used m...

Temporal trends in anticoagulation management for US active duty personnel with atrial ...
BMJ Open; Keithler AN, Wilson AS et. al.

Nov 30th, 2022 - ObjectivesThis study aims to investigate US active duty (AD) military members diagnosed with atrial fibrillation (AF) and the temporal trends of systemic anticoagulation (AC). Our secondary objective is to study the AC prescriptions in AD military...

Factors Associated with Anticoagulation Initiation for New Atrial Fibrillation in an Ur...
Ethnicity & Disease; Seiden J, Lessen S et. al.

Nov 18th, 2022 - To explore factors associated with anticoagulation (AC) initiation after atrial fibrillation (AF) diagnosis. Retrospective cohort study. Urban medical center. Adults with emergency department (ED) diagnosis of new onset AF from 1/1/2017-1/1/2020 d...

Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with...
European Heart Journal; Hijazi Z, Benz AP et. al.

Nov 17th, 2022 - Biomarkers specifically related to atrial tissue may increase the understanding of the pathophysiology of atrial fibrillation (AF) and further improve risk prediction in this setting. Bone morphogenetic protein 10 (BMP10) is a protein expressed in...

Left atrial appendage occlusion with Watchman device after incomplete surgical ligation.
BMJ Case Reports; Manongi N, Volodarskiy A et. al.

Nov 16th, 2022 - Non-valvular atrial fibrillation (NVAF) is the most common cause of cardioembolic stroke. The left atrial appendage (LAA) is the major source of cardiac emboli in patients with NVAF. Anticoagulation (AC) is the standard of care for stroke preventi...

see more →

Drugs  1 results

Regiocit - sodium chloride, sodium citrate injection, solution-Baxter Healthcare Corporation

Aug 13th, 2020 - SPL UNCLASSIFIED SECTION FACT SHEET FOR HEALTHCARE PROVIDERS REGIOCIT (Sodium Chloride and Sodium Citrate Renal Replacement and Regional Anticoagulant solution) For continuous renal replacement therapy For extracorporeal use only Emergency Use Aut...

see more →

News  52 results

Warfarin Worsens Aortic Stenosis Outcomes vs DOACs, Study Hints

Jul 11th, 2022 - Patients with aortic valve disease were often excluded from the major trials that ushered the direct oral anticoagulants (DOACs) into practice, largely supplanting warfarin and other vitamin K antagonists (VKA). But they are key to a recent body o...

Fast Five Quiz: Anticoagulation in Older Patients With Atrial Fibrillation

Mar 9th, 2022 - Older patients with atrial fibrillation (AF) are included in the group of patients at high risk for stroke. A multidisciplinary approach to managing AF in older patients can mitigate risk for stroke. Oral anticoagulation is the cornerstone of mana...

Half-Dose DOACs Cut Bleeding, Thrombus Risk Post-Watchman LAA Closure

Oct 15th, 2021 - In a potential case of "less is more," an antithrombotic regimen with only short-term antiplatelets and long-term reliance on direct oral anticoagulants (DOACs) — but at half the standard dosages — led to an almost 90% drop in risk of thromboembol...

AF a Stroke Cause or Innocent Bystander? The Debate Continues

Oct 4th, 2021 - Discovery of substantial atrial fibrillation (AF) is usually an indication to start oral anticoagulation (OAC) for stroke prevention, but it's far from settled whether such AF is actually a direct cause of thromboembolic stroke. And that has impli...

Amulet Bests Watchman for LAAO But Not for Bleeding: AMULET-IDE

Aug 30th, 2021 - Abbott's Amplatzer Amulet provided superior left atrial appendage (LAA) closure over the old-guard Watchman (Boston Scientific) device but failed to significantly cut stroke or bleeding rates in patients with atrial fibrillation, despite theoretic...

see more →